Gross Profit: Revenues from operations less the associated costs.
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Gross Profit data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.21M |
|
-- |
|
|
Gross Profit |
-- |
$0.82M |
|
$-0.82M |
|
$-1.39M |
|
$-2.21M |
|
$-2.21M |
|
$-2.21M |
|
$-2.21M |
|
$-2.21M |
|
$-2.21M |
|
$-0.82M |
|
$-0.78M |
|
1.02M |
|
1.02M |
|
$-1.52 |
|
$-1.52 |
|
| Balance Sheet Financials | |
$1.31M |
|
$0.00M |
|
$3.09M |
|
$4.40M |
|
$1.73M |
|
-- |
|
$0.26M |
|
$1.99M |
|
$2.41M |
|
$2.41M |
|
$2.41M |
|
1.06M |
|
| Cash Flow Statement Financials | |
$-1.56M |
|
-- |
|
$0.45M |
|
$2.07M |
|
$0.97M |
|
$-1.10M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-91.41% |
|
-91.41% |
|
-50.12% |
|
-91.41% |
|
$2.27 |
|
$-1.53 |
|
$-1.53 |
|